Skip to main content
. 2025 Jan 13;16(5):929–936. doi: 10.1007/s13193-025-02190-2

Table 2.

Univariate analysis (UA) of clinical, surgical and demographic factors for tumor recurrence, with their respective confidence Interval (CI) and “P” value. Multivariate analysis (MA) of clinical, surgical and demographic factors of tumor recurrence, with their respective confidence interval (CI) and “P” value. *Statistically significant value. OR, odds ratio; CC, cubic centimeters; CPA, cerebellopontine angle

Factor for UA OR (CI 95%) P value
Age 60 years 1.74 (0.81–3.75) 0.15
Simpson 1 0.15 (0.07–0.34) 0.000*
Simpson 2 0.50 (0.27–0.93) 0.026*
Simpson 3 1.26 (0.32–4.88) 0.729
Simpson 4 57 (13.01–248) 0.000*
Simpson 5 1.04 (0.98–1.04) 0.209
Pain/headache 0.65 (0.36–1.18) 0.164
Motor deficit 1.00 (0.53–1.88) 0.995
Sensitive deficit 0.41 (0.13–1.31) 0.126
Seizure 0.76 (0.37–1.54) 0.45
Cranial nerve deficit 2.1 (1.10–4.27) 0.023*
Intracranial hypertension syndrome 5 (2.06–12.08) 0.000*
Cerebellar syndrome 1.05 (1–1.11) 0.011*
Post-surgical improvement 0.14 (0.06–0.35) 0.000*
Tumor size resected 60 cc 1.13 (0.61–2.08) 0.686
Surgical time > 280 min 3.12 (1.70–5.72) 0.00*
Bleeding > 850 ml 1.34 (0.74–2.41) 0.32
Meningothelial 1.08 (0.55–2.12) 0.811
Fibroblastic 0.70 (0.27–1.81) 0.466
Transitional 0.98 (0.54–1.78) 0.949
Psammomatous 2.31 (0.70–7.06) 0.155
Angiomatous 0.30 (0.03–2.65) 0.255
Microcystic 0.78 (0.07–8.76) 084
Metaplastic 1.57 (0.97–25.57) 0.74
Chordoid 1.57 (0.97–25.57) 0.74
Clear cells 0.51 (0.53–5.05) 0.56
Atypical 1.19 (0.39–3.58) 0.75
Rhabdoid 0.99 (0.97–1) 0.42
Anaplastic 1.57 (0.09–25.57) 0.74
Convexity 0.23 (0.11–0.51) 0.00*
Sickle 1.10 (0.40–3.05) 0.84
Parassagital 0.50 (0.20–1.25) 0.13
Tentorial 1.37 (0.44–4.26) 0.58
Clinoid 1.95 (0.57–6.66) 0.27
Sphenoid 2.10 (0.79–5.61) 0.12
Petroclival 15.92 (1.97–128.58) 0.00*
CPA 5.95 (1.20–29.50) 0.01*
Sellar tuberculum 4.13 (0.78–21.87) 0.07
Olfactory groove 0.77 (0.13–4.35) 0.77
Factor for MA OR (IC 95%) P value
Pain/headache 1.34 (0.40–4.51) 0.63
Motor deficit 1.22 (0.32–4.60) 0.76
Sensitive deficit 0.65 (0.08–5.13) 0.68
Seizure 1.94 (0.47–8.25) 0.36
Cranial nerve deficit 1.06 (0.14–7.29) 0.95
Intracranial hypertension syndrome 8.58 (1.64–44.68) 0.01*
Post-surgical improvement 0.15 (0.04–0.60) 0.007*
Tumor size resected 60 cc 2.95 (0.80–10.85) 0.10
Surgical time > 280 min 2.19 (0.66–7.29) 0.19*
Bleeding > 850 ml 1.01 (0.31–3.32) 0.97
Meningothelial 2.36 (0.03–167) 0.69
Fibroblastic 1.42 (0.01–144) 0.88
Transitional 1.97 (0.02–135) 0.75
Psammomatous 11.1 (0.10–1246) 0.31
Microcystic 5.92 (0.04–865) 0.48
Metaplastic 0.69 (0.00–1440) 0.92
Chordoid 0.09 (0.00–56,267) 0.72
Clear Cells 0.19 (0.00–67) 0.58
Atypical 6.59 (0.07–575) 0.40
Convexity 0.307 (0.27–3.46) 0.34
Sickle 0.63 (0.04–8.56) 0.73
Parassagital 0.37 (0.35–4.04) 0.42
Tentorial 2.38 (0.17–33.06) 0.51
Clinoid 0.58 (0.02–13.92) 0.74
Sphenoid 0.20 (0.01–3.33) 0.26
Petroclival 16.91 (0.31–906) 0.16
CPA 5.01 (0.15–165.80) 0.36
Sellar tuberculum 1.19 (0.02–59.15) 0.92
Olfactory groove 0.01 (0.00–1.36) 0.06